Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 8;7:90. doi: 10.1038/s41523-021-00297-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — Kaplan–Meier survival curves with Log-rank Hazard ratios for cases of ER+ve, HER2−ve breast cancer from the entire TEAM cohort for Oncotype-trained (Panel a), Prosigna-trained (Panel b), and Mammaprint-trained results (Panel c) and for ER+ve, HER2−ve Node negative breast cancers treated without chemotherapy from the TEAM cohort for Oncotype-trained (Panel d), Prosigna-trained (Panel e), and Mammaprint-trained results (Panel 5). Log-Rank P values for each test are in brackets. Within each panel low (green), moderate (blue) and high (red) risk survival curves are plotted with LogRank Hazard ratios for high risk and intermediate risk (Oncotype-trained and Prosigna-trained only) calculated against low risk cases in each sub-group. 95% Confidence intervals for LogRank Hazard ratios are in brackets. For each group the number at risk (Low, moderate, high) are presented under the X axis.